Prenetics Shares Rise After Q2 FY2026 Results, Positive Cash Flow and Raised Guidance
Prenetics surged in pre-market trade after releasing Q2 FY2026 results showing $46.5 million in revenue - a near-tripling year-over-year and squarely inside its $46–$48 million guidance. The IM8 wellness brand accounted for $45.0 million of the quarter, marking a roughly 359% increase year-over-year and the sixth consecutive record quarter. Managem…